Navigation Links
Barriers will not stop convergence of medical technologies

When a patient presents to a doctor, many assessments have to be made leading to complex decision trees throughout the process of what is unglamorously called managing the patient.

During residency, which is not the free-for-all carnival that Gray's Anatomy would have us believe, one of the most important judgment calls that is learned is whether the patient......

Full article >>> disease undergoes chemotherapy. And in many cases, the increasing realization that even localized disease can often harbor cancer stem cells throughout the body means that surgery is not uncommonly combined with more generalized medical therapies.

Some conditions - such as back pain - can have either surgical or medical treatment options in which it is not definitively clear which appro......

Full article >>> > Is diabetes a medical or a surgical disease?

Nearly everyone will correctly identify diabetes as a medical disease caused by a relative lack of insulin in these patients. The paucity (and in some cases complete lack) of insulin has many effects. The most important is an increase in blood sugar which results from the fact that liver and muscle cells, which normally under the inf......

Full article >>> a. Oxygen-rich arterial blood from the heart enters these organs which then drain into veins that lead back to the heart. The pancreas, which is the organ that secretes insulin in response to glucose levels, doesn't actually follow this simple paradigm. Blood flowing to the pancreas does, indeed, come from the heart but the blood (now supplemented with insulin) leaving the pancreas actually ent......

Full article >>> proven, nor should they be considered as a basis for modifying any particular patient's treatment. In addition, this discussion pertains to insulin-dependent diabetes and important measures such as diet and exercise, which are critical for all diabetics, including those with non-insulin dependent diabetes.

The point, however, is that a surgical (namely, a more anatomically localized) ap......

Full article >>> edside (or more accurately inside the patient). The surgery/medicine divide is not just a scientific/technical issue but also reflective of significant cultural differences among specialties. The official name of my medical school alma mater - the Columbia University College of Physicians and Surgeons - exemplifies this traditional dichotomy bet......

Full article >>> r> Ogan Gurel: And the winners in medical design are

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):